Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Ovid Therapeutics to Host Investor Event
-
Barinthus Bio Announces Late Breaking Presentation at AASLD 2024 – The Liver Meeting® and Attendance at November Conferences
-
Athene Announces CFO Martin P. Klein to Retire from Role
-
Mangoceuticals, Inc. Regains Full Compliance with Nasdaq Minimum Bid Price Requirement
-
PodcastOne Engages MZ Group to Lead Strategic Investor Relations Program
-
aTyr Pharma to Present at Upcoming Investor Conferences
-
Autonomix Medical, Inc. Reports New Positive Topline Results from First 15 Patients’ 7-Day Data Highlighting Significant Impact on Treatment of Pancreatic Cancer Pain with Maintained Pain Reduction
-
Konica Minolta Healthcare and Quinsite Partner to Bring Comprehensive Workflow and Operational Analytics to Exa Platform Users
-
BD² and DBSA Partner to Improve the Lives of People Living With Bipolar Disorder
-
Absci and Twist Bioscience Collaborate to Design Novel Antibody using Generative AI
-
UYBA Volley Battles Back with Consecutive Wins in Serie A1
-
Nearly 80% of Consumers Consider Phone Channel Important for Communicating with Businesses, Despite Reluctance to Answer Calls
-
Sensus Healthcare to Host Third Quarter 2024 Financial Results and Business Update Conference Call on Thursday, November 14, 2024
-
Outbrain Deepens Collaboration with Microsoft – Integrates AI Solutions into Its Offerings
-
The Geological Society of America Acquires Mountain Press Publishing Company’s Renowned Geology Book Series
-
Cocrystal Pharma’s Co-CEOs Highlight Pioneering Approach to Antiviral Drug Candidates Targeting Influenza and Coronaviruses as Fall Flu and COVID Season Begins
-
Panbela to Host Third Quarter 2024 Earnings Conference Call on November 14, 2024
-
Crown to Report Third Quarter 2024 Results on November 14, 2024
-
IRADIMED CORPORATION Announces Third Quarter of 2024 Financial Results and the Declaration of its Regular Quarterly Cash Dividend of $0.15 Per Share
-
Deepfake Fraud Costs the Financial Sector an Average of $600,000 for Each Company, Regula’s Survey Shows
-
Solid Biosciences to Participate at the Truist Securities BioPharma Symposium
-
Monster Beverage to Report Financial Results for 2024 Third Quarter on November 7, 2024
-
Resilinc Announces Chris Lanier as New Chief Technology Officer
-
Spur Therapeutics Publishes Preclinical Proof-of-Concept Data for SBT101, its Gene Therapy Candidate in Adrenomyeloneuropathy (AMN)
-
Nautilus Biotechnology Co-founder and Chief Scientist Parag Mallick, Ph.D., Honored with the Academy for Radiology and Biomedical Imaging Research’s Distinguished Investigator Award
-
Vertex Advances Tax Technology Innovation at Exchange 2024
-
Esperion Announces a Featured Presentation in the Late Breaker/Featured Science Track and Three Poster Presentations Accepted for the 2024 American Heart Association (AHA) Scientific Sessions
-
VEON to release 3Q 2024 trading update on 14 November 2024
-
Evaxion announces business update and third quarter 2024 financial results
-
Oxford BioTherapeutics to Present at World ADC Conference 2024
-
Eagle Pharmaceuticals Adopts Limited Duration Stockholder Rights Plan
-
Foresight Ventures Co-hosts Neo X Grind Hackathon, Accessing $22 Million Funding to Propel Blockchain Innovation and Adoption
-
BioNTech to Host Innovation Series R&D Day on November 14, 2024
-
Stack Capital Group Inc. Reports Q3-24 Financial Results
-
BioNTech to Host Innovation Series R&D Day on November 14, 2024
-
Appendix 4C – Q1 FY25 Quarterly Cash Flow Report
-
Form 8.3 - I3 ENERGY PLC
-
Parker Reports Fiscal 2025 First Quarter Results
-
CoreCard Corporation Reports Third Quarter 2024 Results
-
500 Cycles Major Milestone: Novacium’s Silicon-Based Anode Batteries Demonstrate High Capacity and High Durability
-
Red Pine Discovers Significant Gold Mineralization in Faulted Extension of the Jubilee Shear on the Wawa Gold Project
-
Notice of Knight Therapeutics' Third Quarter 2024 Results Conference Call
-
Tourmaline Bio to Present at Upcoming Investor Conferences
-
InHouse by MariMed Launches Help on the Homefront, to Support Veterans Facing Housing Challenges
-
Psyence Biomedical Announces Closing of Previously Announced Acquisition of Psyence Group’s Stake in PsyLabs
-
Kura Oncology to Report Third Quarter 2024 Financial Results
-
Angus Gold Commences Fall Drilling Program on Dorset Gold Zone, Golden Sky Project, Wawa
-
Repligen to Report Third Quarter 2024 Financial Results
-
Kymera Therapeutics Announces Third Quarter 2024 Financial Results and Provides a Business Update
-
Intellia Therapeutics Announces Two Upcoming Investor Events in November 2024
